Search Login Register

exenatide (Byetta) Summary

Description: amino acid sequence given in first source; isolated from the venom of the lizard Heloderma suspectum; increases pancreatic acinar cAMP; identical to exendin-3 except that Gly(2)-Glu(3) replaces Ser(2)-Asp(3); exenatide is a synthetic version of exendin-4; has antidiabetic and antiobesity activities; binds to GLP-1 receptor

Also Known As: Byetta; AC 2993; AC 2993 LAR; Ex4 peptide; exendin 4 Show All >>

Networked: 853 relevant articles (144 outcomes, 210 trials/studies) for this Drug

Key Diseases for which exenatide is Relevant

  1. Weight Loss (Weight Reduction) : 34 outcomes 42 studies in 166 results
  2. Body Weight (Weight, Body) : 27 outcomes 25 studies in 162 results
  3. Type 2 Diabetes Mellitus (MODY) : 18 outcomes 38 studies in 182 results
  4. Hypoglycemia (Reactive Hypoglycemia) : 9 outcomes 16 studies in 76 results
  5. Obesity : 8 outcomes 16 studies in 58 results
Show All >>

Drugs Related to exenatide

  1. Glucose (Dextrose)
  2. Glucagon-Like Peptide 1 (GLP 1)
  3. Insulin (Novolin)
  4. liraglutide
  5. Metformin (Glucophage)
  6. glucagon-like peptide receptor (receptor, glucagon-like peptide)
  7. Incretins
  8. glargine (insulin glargine)
  9. sitagliptin (Januvia)
  10. exenatide (Byetta)
Show All >>

Therapies Related to exenatide

  1. Injections
  2. Gastric Bypass (Roux-en-Y Gastric Bypass)
  3. Intravenous Infusions
  4. Transplantation (Transplant Recipients)
  5. Microspheres (Microsphere)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.